3-[3-(2-BROMO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
Compound with spectra: 1 NMR
![3-[3-(2-BROMO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE](/api/compound/3GmcXj02bI7.png?ph=true&h=300&w=458 "3-[3-(2-BROMO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE")
| SpectraBase Compound ID | 3GmcXj02bI7 |
|---|---|
| InChI | InChI=1S/C25H20BrFN4O2/c1-2-31-21-6-4-3-5-17(21)19-14-16(8-10-22(19)31)28-23(32)11-12-24-29-25(30-33-24)18-9-7-15(27)13-20(18)26/h3-10,13-14H,2,11-12H2,1H3,(H,28,32) |
| InChIKey | ZRDYMSKIQKJZIQ-UHFFFAOYSA-N |
| Mol Weight | 507.36 g/mol |
| Molecular Formula | C25H20BrFN4O2 |
| Exact Mass | 506.075367 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-[3-(4-AMINO-2-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
(2E)-2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-propenenitrile
(2E)-2-[4-(3-bromophenyl)-1,3-thiazol-2-yl]-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-propenenitrile
2,5-dimethyl-1-(9-ethylcarbazol-3-yl)pyrrole-3-carboxaldehyde
acetic acid, [(1-ethyl-1H-benzimidazol-2-yl)thio]-, 2-[(E)-(9-ethyl-9H-carbazol-3-yl)methylidene]hydrazide
acetic acid, [[4-ethyl-5-(4-methoxyphenyl)-4H-1,2,4-triazol-3-yl]thio]-, 2-[(E)-(9-ethyl-9H-carbazol-3-yl)methylidene]hydrazide
5-(9-(2-Ethylhexyl)-9H-carbazol-3-yl)furan-2-carbaldehyde
9H-carbazole, 9-ethyl-3-[[4-(2-naphthalenylsulfonyl)-1-piperazinyl]methyl]-
N,N'-((9-ethyl-9H-carbazole-3,6-diyl)bis((1-(tert-butyl)-1H-tetrazol-5-yl)methylene))bis(4-methylaniline)
MPIOBDSNJKATHS-UHFFFAOYSA-N
| Title | Journal or Book | Year |
|---|---|---|
| Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation | Organic and Medicinal Chemistry Letters | 2012 |